Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session IV: Lymphoma
Debate – Patients With Early Progressing Follicular Lymphoma Generally Should Receive CAR-T Therapy Vs Other Newer Agents After Two Lines Of Therapy (Yes/No) = Novel Agents
Thursday, June 23, 2022
9:30 AM – 9:45 AM
Debate Speaker(s)
Kami J. Maddocks, MD
Physician
James Cancer Hospital, Ohio State University
Columbus, Ohio